VITL raises $7.5M to streamline e-prescribing for cash-pay clinics

On Wednesday, VITL announced that it has raised $7.5 million in a Series A funding round led by venture firm SignalFire. The 18-month-old startup secured the funding to scale its e-prescribing platform, which is built specifically to serve cash-pay medical businesses.

The company is solving a tech bottleneck for healthcare providers who operate outside the traditional insurance system. Currently, many cash-pay clinics rely on software designed for insurance-based care, which often complicates administrative workflows. This is particularly true when clinics interact with compounding pharmacies—defined as pharmacies that create custom medications to order. According to Charlie Jordan, the founder and CEO of VITL, the startup’s platform directly targets these inefficiencies. “We shorten the prescription time from several minutes down to a few seconds,” Jordan said. By automating these administrative tasks, VITL estimates that its technology saves its clients up to two full workdays per month.

The platform has seen rapid adoption since its launch. To date, VITL has onboarded more than 630 clinics. Driven by this demand, the startup is on pace to bring in at least $10 million per year in annualized recurring revenue (ARR). Much of this growth is fueled by the rising popularity of specialized medical treatments. This includes demand for GLP-1s –the class of drugs that includes Ozempic and Wegovy — peptides, and aesthetic procedures like Botox. Despite its rapid growth, the company’s current customer base of more than 630 clinics represents only a fraction of the tens of thousands of cash-pay clinics operating across the U.S.

To capture more of this market, VITL must compete with established players in the healthcare software space. These competitors include Surescripts, the industry’s e-prescribing pioneer, as well as Jane Software, a boutique clinic platform that bundles prescription features into its broader electronic health record software. However, VITL differentiates itself from both Surescripts and Jane Software by focusing its product entirely on the unique workflow requirements of the cash-pay medical sector.

Why it matters

VITL is addressing a tech bottleneck in the cash-pay medical sector by providing an e-prescribing platform tailored for clinics that rely on software built for traditional, insurance-based care. As consumer demand for out-of-pocket medical treatments increases, specialized digital infrastructure is becoming essential to handle workflows that traditional healthcare software cannot support.